- £123.19m
- £117.00m
- £38.44m
PDMR Shareholding/SIP and TVR
Issue of Share Options/PDMR Shareholdings
Brief: Diaceutics Grows Revenues By 24% In H1
Brief: Diaceutics Says Deborah Davis, Non-Executive Chair To Step Down
Board Changes
Revenue growth of 24% in H1 with 55% now recurring
Senior Management Appointments
PDMR Shareholding/SIP and Total Voting Rights
"Precision Medicine in Oncology " Virtual Event
Europe Research Roundup: Allianz, Carnival, Future
Notice of AGM and Posting of Annual Report
Director / PDMR Shareholding
Revenue growth of 22% & order book growth of 57%
Notice of Results & Presentations
PDMR Shareholding/SIP and TVR
Appointment of Amie Mc Neice as VP of Marketing
PDMR Shareholding/Share Incentive Plan
Director/PDMR/PCA Shareholding & TR1
Significant upgrade to Diaceutics' DXRX platform